Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kowey

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Cardiology Reports|September 8, 2006
Atrial fibrillation: choosing an antiarrhythmic drugTodd Rudo, Peter Kowey
Heart Rhythm|January 12, 2023
Amiodarone for the prevention of shocks and death in patients with implantable cardioverter-defibrillators: Hero or villain?Jenna Spears, Peter Kowey
Pacing and Clinical Electrophysiology : PACE|March 11, 2009
One small stepMichael Link, Peter Kowey
Journal of Cardiac Failure|December 20, 2005
Does "anti-lipid" also mean "anti-arrhythmic"?Douglas Esberg, Peter Kowey
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 9, 2014
The thorough QT study: Is its demise on the horizon?Philip T Sager, Peter Kowey
Circulation|August 29, 2022
I'm Sorry, Ms Jones, But We Cannot Make You Feel Better TodaySteven Liskov, Luiz Belardinelli, Peter Kowey
Heart, Lung & Circulation|August 6, 2017
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017Logan Kanagaratnam, Peter Kowey, David Whalley
Indian Pacing and Electrophysiology Journal|November 30, 2025
Dofetilide in atrial fibrillation: A comprehensive reviewDiksha Mahendru, Harin D Joshi, Peter Kowey
Journal of Cardiovascular Electrophysiology|May 4, 2025
Antiarrhythmic Drug Initiation for Atrial Fibrillation in the USA: How and WhereJoshua Newman, Adam Strickberger, Jenna Spears, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2018
Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced ConstipationWilliam B White, Peter Kowey, Ulysses Diva, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Cardiology Reports|September 8, 2006
Atrial fibrillation: choosing an antiarrhythmic drugTodd Rudo, Peter Kowey
Heart Rhythm|January 12, 2023
Amiodarone for the prevention of shocks and death in patients with implantable cardioverter-defibrillators: Hero or villain?Jenna Spears, Peter Kowey
Pacing and Clinical Electrophysiology : PACE|March 11, 2009
One small stepMichael Link, Peter Kowey
Journal of Cardiac Failure|December 20, 2005
Does "anti-lipid" also mean "anti-arrhythmic"?Douglas Esberg, Peter Kowey
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 9, 2014
The thorough QT study: Is its demise on the horizon?Philip T Sager, Peter Kowey
Circulation|August 29, 2022
I'm Sorry, Ms Jones, But We Cannot Make You Feel Better TodaySteven Liskov, Luiz Belardinelli, Peter Kowey
Heart, Lung & Circulation|August 6, 2017
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017Logan Kanagaratnam, Peter Kowey, David Whalley
Indian Pacing and Electrophysiology Journal|November 30, 2025
Dofetilide in atrial fibrillation: A comprehensive reviewDiksha Mahendru, Harin D Joshi, Peter Kowey
Journal of Cardiovascular Electrophysiology|May 4, 2025
Antiarrhythmic Drug Initiation for Atrial Fibrillation in the USA: How and WhereJoshua Newman, Adam Strickberger, Jenna Spears, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2018
Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced ConstipationWilliam B White, Peter Kowey, Ulysses Diva, et al.
Pageof 5